Berkeley, CA, United States of America

Ivan Lieberburg

USPTO Granted Patents = 10 


 

Average Co-Inventor Count = 1.8

ph-index = 6

Forward Citations = 129(Granted Patents)


Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ivan Lieberburg in Autoimmune Disease Treatment

Introduction

Ivan Lieberburg, a prominent inventor based in Berkeley, CA, is recognized for his significant contributions to the medical field, specifically in the treatment of inflammatory and autoimmune diseases. With a portfolio of ten patents to his name, Lieberburg’s innovations have paved the way for new therapeutic approaches that enhance patient safety and treatment efficacy.

Latest Patents

Among his latest patents, Lieberburg has focused on methods of treating inflammatory and autoimmune diseases using natalizumab. This treatment has been established as both safe and effective for conditions such as multiple sclerosis, Crohn's Disease, and rheumatoid arthritis. Notably, while natalizumab is generally effective, rare occurrences of progressive multifocal leucoencephalopathy (PML) during treatment have prompted the need for vigilant monitoring. Lieberburg's approach emphasizes the importance of screening for the JC virus (JCV) and providing comprehensive information to caregivers and patients regarding the signs of PML. This proactive strategy aims to optimize the safety profile of natalizumab therapy.

Career Highlights

Throughout his career, Ivan Lieberburg has worked with well-respected companies in the pharmaceutical industry, including Wyeth and Elan Pharmaceuticals, Inc. His role in these organizations has enabled him to drive forward innovations that address complex health challenges related to autoimmune and inflammatory conditions.

Collaborations

Lieberburg has collaborated with a notable team of professionals, including James Callaway and Michael Grundman. Their combined expertise in research and development has been integral to Lieberburg's pioneering work in introducing new therapies aimed at improving patient outcomes in inflammatory disease treatment.

Conclusion

Ivan Lieberburg's innovative contributions to the field of medicine, particularly concerning autoimmune conditions, underscore the importance of thoughtful and rigorous patent development. His dedication to enhancing treatment safety and effectiveness has solidified his reputation as a leading inventor in his field, inspiring future efforts in medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…